nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—Cholecystitis—Sorafenib—liver cancer	0.0176	0.0333	CcSEcCtD
Pentoxifylline—Caffeine—PIK3CB—liver cancer	0.0169	0.29	CrCbGaD
Pentoxifylline—Caffeine—PIK3CD—liver cancer	0.0169	0.29	CrCbGaD
Pentoxifylline—Oropharyngeal discomfort—Sorafenib—liver cancer	0.0139	0.0263	CcSEcCtD
Pentoxifylline—Leukaemia—Epirubicin—liver cancer	0.0139	0.0263	CcSEcCtD
Pentoxifylline—Caffeine—PIK3CA—liver cancer	0.0131	0.224	CrCbGaD
Pentoxifylline—Leukaemia—Doxorubicin—liver cancer	0.0128	0.0243	CcSEcCtD
Pentoxifylline—Influenza like illness—Sorafenib—liver cancer	0.00982	0.0186	CcSEcCtD
Pentoxifylline—Lacrimation—Epirubicin—liver cancer	0.00636	0.012	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Sorafenib—liver cancer	0.00608	0.0115	CcSEcCtD
Pentoxifylline—Lacrimation—Doxorubicin—liver cancer	0.00588	0.0111	CcSEcCtD
Pentoxifylline—Theobromine—CYP2E1—liver cancer	0.00566	0.0971	CrCbGaD
Pentoxifylline—Infestation—Sorafenib—liver cancer	0.00566	0.0107	CcSEcCtD
Pentoxifylline—Infestation NOS—Sorafenib—liver cancer	0.00566	0.0107	CcSEcCtD
Pentoxifylline—Jaundice—Sorafenib—liver cancer	0.00552	0.0104	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Sorafenib—liver cancer	0.00535	0.0101	CcSEcCtD
Pentoxifylline—Epistaxis—Sorafenib—liver cancer	0.00534	0.0101	CcSEcCtD
Pentoxifylline—Laryngitis—Epirubicin—liver cancer	0.00519	0.00982	CcSEcCtD
Pentoxifylline—Haemoglobin—Sorafenib—liver cancer	0.00511	0.00967	CcSEcCtD
Pentoxifylline—Haemorrhage—Sorafenib—liver cancer	0.00508	0.00962	CcSEcCtD
Pentoxifylline—Scotoma—Epirubicin—liver cancer	0.00492	0.00932	CcSEcCtD
Pentoxifylline—Laryngitis—Doxorubicin—liver cancer	0.0048	0.00909	CcSEcCtD
Pentoxifylline—Flushing—Sorafenib—liver cancer	0.00471	0.00893	CcSEcCtD
Pentoxifylline—Immune system disorder—Sorafenib—liver cancer	0.00459	0.00869	CcSEcCtD
Pentoxifylline—Scotoma—Doxorubicin—liver cancer	0.00455	0.00862	CcSEcCtD
Pentoxifylline—Arrhythmia—Sorafenib—liver cancer	0.00454	0.00859	CcSEcCtD
Pentoxifylline—Erythema—Sorafenib—liver cancer	0.00442	0.00837	CcSEcCtD
Pentoxifylline—Dysgeusia—Sorafenib—liver cancer	0.00433	0.0082	CcSEcCtD
Pentoxifylline—Muscle spasms—Sorafenib—liver cancer	0.00425	0.00805	CcSEcCtD
Pentoxifylline—Anaemia—Sorafenib—liver cancer	0.00409	0.00774	CcSEcCtD
Pentoxifylline—Lacrimation increased—Epirubicin—liver cancer	0.00406	0.00768	CcSEcCtD
Pentoxifylline—Angioedema—Sorafenib—liver cancer	0.00404	0.00765	CcSEcCtD
Pentoxifylline—Leukopenia—Sorafenib—liver cancer	0.00396	0.00749	CcSEcCtD
Pentoxifylline—Hypertension—Sorafenib—liver cancer	0.00382	0.00723	CcSEcCtD
Pentoxifylline—Myalgia—Sorafenib—liver cancer	0.00376	0.00713	CcSEcCtD
Pentoxifylline—Lacrimation increased—Doxorubicin—liver cancer	0.00375	0.00711	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00374	0.00708	CcSEcCtD
Pentoxifylline—Dry mouth—Sorafenib—liver cancer	0.00368	0.00697	CcSEcCtD
Pentoxifylline—Eructation—Epirubicin—liver cancer	0.00367	0.00695	CcSEcCtD
Pentoxifylline—Salivary hypersecretion—Epirubicin—liver cancer	0.00363	0.00687	CcSEcCtD
Pentoxifylline—Influenza like illness—Epirubicin—liver cancer	0.00363	0.00687	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Sorafenib—liver cancer	0.00361	0.00683	CcSEcCtD
Pentoxifylline—Infection—Sorafenib—liver cancer	0.00359	0.00679	CcSEcCtD
Pentoxifylline—Shock—Sorafenib—liver cancer	0.00355	0.00672	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Sorafenib—liver cancer	0.00353	0.00669	CcSEcCtD
Pentoxifylline—Aplastic anaemia—Epirubicin—liver cancer	0.00351	0.00664	CcSEcCtD
Pentoxifylline—Skin disorder—Sorafenib—liver cancer	0.00351	0.00664	CcSEcCtD
Pentoxifylline—Anorexia—Sorafenib—liver cancer	0.00344	0.00651	CcSEcCtD
Pentoxifylline—Cramps of lower extremities—Epirubicin—liver cancer	0.00343	0.0065	CcSEcCtD
Pentoxifylline—Eructation—Doxorubicin—liver cancer	0.0034	0.00643	CcSEcCtD
Pentoxifylline—Salivary hypersecretion—Doxorubicin—liver cancer	0.00336	0.00636	CcSEcCtD
Pentoxifylline—Influenza like illness—Doxorubicin—liver cancer	0.00336	0.00636	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00329	0.00622	CcSEcCtD
Pentoxifylline—Aplastic anaemia—Doxorubicin—liver cancer	0.00325	0.00615	CcSEcCtD
Pentoxifylline—Dyspnoea—Sorafenib—liver cancer	0.00322	0.00609	CcSEcCtD
Pentoxifylline—Cramps of lower extremities—Doxorubicin—liver cancer	0.00318	0.00602	CcSEcCtD
Pentoxifylline—Dyspepsia—Sorafenib—liver cancer	0.00318	0.00601	CcSEcCtD
Pentoxifylline—Decreased appetite—Sorafenib—liver cancer	0.00314	0.00594	CcSEcCtD
Pentoxifylline—Constipation—Sorafenib—liver cancer	0.00309	0.00584	CcSEcCtD
Pentoxifylline—Vascular purpura—Epirubicin—liver cancer	0.00303	0.00574	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Sorafenib—liver cancer	0.00295	0.00559	CcSEcCtD
Pentoxifylline—Caffeine—CYP2E1—liver cancer	0.00291	0.0499	CrCbGaD
Pentoxifylline—Caffeine—CYP1A1—liver cancer	0.00287	0.0493	CrCbGaD
Pentoxifylline—Urticaria—Sorafenib—liver cancer	0.00287	0.00543	CcSEcCtD
Pentoxifylline—Abdominal pain—Sorafenib—liver cancer	0.00285	0.0054	CcSEcCtD
Pentoxifylline—Body temperature increased—Sorafenib—liver cancer	0.00285	0.0054	CcSEcCtD
Pentoxifylline—Purpura—Epirubicin—liver cancer	0.00282	0.00533	CcSEcCtD
Pentoxifylline—Vascular purpura—Doxorubicin—liver cancer	0.00281	0.00531	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Epirubicin—liver cancer	0.0028	0.00531	CcSEcCtD
Pentoxifylline—Hypersensitivity—Sorafenib—liver cancer	0.00266	0.00503	CcSEcCtD
Pentoxifylline—Purpura—Doxorubicin—liver cancer	0.00261	0.00493	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00259	0.00491	CcSEcCtD
Pentoxifylline—Asthenia—Sorafenib—liver cancer	0.00259	0.0049	CcSEcCtD
Pentoxifylline—Pruritus—Sorafenib—liver cancer	0.00255	0.00483	CcSEcCtD
Pentoxifylline—Diarrhoea—Sorafenib—liver cancer	0.00247	0.00467	CcSEcCtD
Pentoxifylline—Dizziness—Sorafenib—liver cancer	0.00239	0.00452	CcSEcCtD
Pentoxifylline—Abdominal distension—Epirubicin—liver cancer	0.00236	0.00447	CcSEcCtD
Pentoxifylline—Vomiting—Sorafenib—liver cancer	0.00229	0.00434	CcSEcCtD
Pentoxifylline—Angina pectoris—Epirubicin—liver cancer	0.00228	0.00433	CcSEcCtD
Pentoxifylline—Rash—Sorafenib—liver cancer	0.00228	0.00431	CcSEcCtD
Pentoxifylline—Dermatitis—Sorafenib—liver cancer	0.00227	0.0043	CcSEcCtD
Pentoxifylline—Headache—Sorafenib—liver cancer	0.00226	0.00428	CcSEcCtD
Pentoxifylline—Pancytopenia—Epirubicin—liver cancer	0.00223	0.00422	CcSEcCtD
Pentoxifylline—Abdominal distension—Doxorubicin—liver cancer	0.00218	0.00414	CcSEcCtD
Pentoxifylline—Nausea—Sorafenib—liver cancer	0.00214	0.00406	CcSEcCtD
Pentoxifylline—Angina pectoris—Doxorubicin—liver cancer	0.00211	0.004	CcSEcCtD
Pentoxifylline—Infestation—Epirubicin—liver cancer	0.00209	0.00396	CcSEcCtD
Pentoxifylline—Drowsiness—Epirubicin—liver cancer	0.00209	0.00396	CcSEcCtD
Pentoxifylline—Infestation NOS—Epirubicin—liver cancer	0.00209	0.00396	CcSEcCtD
Pentoxifylline—Pancytopenia—Doxorubicin—liver cancer	0.00206	0.0039	CcSEcCtD
Pentoxifylline—Jaundice—Epirubicin—liver cancer	0.00204	0.00386	CcSEcCtD
Pentoxifylline—Conjunctivitis—Epirubicin—liver cancer	0.00203	0.00385	CcSEcCtD
Pentoxifylline—Sweating—Epirubicin—liver cancer	0.002	0.0038	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Epirubicin—liver cancer	0.00198	0.00374	CcSEcCtD
Pentoxifylline—Epistaxis—Epirubicin—liver cancer	0.00197	0.00373	CcSEcCtD
Pentoxifylline—Infestation NOS—Doxorubicin—liver cancer	0.00193	0.00366	CcSEcCtD
Pentoxifylline—Infestation—Doxorubicin—liver cancer	0.00193	0.00366	CcSEcCtD
Pentoxifylline—Drowsiness—Doxorubicin—liver cancer	0.00193	0.00366	CcSEcCtD
Pentoxifylline—Haemoglobin—Epirubicin—liver cancer	0.00189	0.00357	CcSEcCtD
Pentoxifylline—Jaundice—Doxorubicin—liver cancer	0.00189	0.00357	CcSEcCtD
Pentoxifylline—Conjunctivitis—Doxorubicin—liver cancer	0.00188	0.00356	CcSEcCtD
Pentoxifylline—Haemorrhage—Epirubicin—liver cancer	0.00188	0.00355	CcSEcCtD
Pentoxifylline—Hepatitis—Epirubicin—liver cancer	0.00188	0.00355	CcSEcCtD
Pentoxifylline—Sweating—Doxorubicin—liver cancer	0.00185	0.00351	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Doxorubicin—liver cancer	0.00183	0.00346	CcSEcCtD
Pentoxifylline—Epistaxis—Doxorubicin—liver cancer	0.00183	0.00346	CcSEcCtD
Pentoxifylline—Haemoglobin—Doxorubicin—liver cancer	0.00175	0.00331	CcSEcCtD
Pentoxifylline—Flushing—Epirubicin—liver cancer	0.00174	0.0033	CcSEcCtD
Pentoxifylline—Haemorrhage—Doxorubicin—liver cancer	0.00174	0.00329	CcSEcCtD
Pentoxifylline—Hepatitis—Doxorubicin—liver cancer	0.00174	0.00329	CcSEcCtD
Pentoxifylline—Immune system disorder—Epirubicin—liver cancer	0.0017	0.00321	CcSEcCtD
Pentoxifylline—Arrhythmia—Epirubicin—liver cancer	0.00168	0.00317	CcSEcCtD
Pentoxifylline—Erythema—Epirubicin—liver cancer	0.00163	0.00309	CcSEcCtD
Pentoxifylline—Flushing—Doxorubicin—liver cancer	0.00161	0.00305	CcSEcCtD
Pentoxifylline—Flatulence—Epirubicin—liver cancer	0.00161	0.00305	CcSEcCtD
Pentoxifylline—Tension—Epirubicin—liver cancer	0.0016	0.00304	CcSEcCtD
Pentoxifylline—Dysgeusia—Epirubicin—liver cancer	0.0016	0.00303	CcSEcCtD
Pentoxifylline—Nervousness—Epirubicin—liver cancer	0.00159	0.003	CcSEcCtD
Pentoxifylline—Back pain—Epirubicin—liver cancer	0.00158	0.00299	CcSEcCtD
Pentoxifylline—Muscle spasms—Epirubicin—liver cancer	0.00157	0.00297	CcSEcCtD
Pentoxifylline—Immune system disorder—Doxorubicin—liver cancer	0.00157	0.00297	CcSEcCtD
Pentoxifylline—Arrhythmia—Doxorubicin—liver cancer	0.00155	0.00294	CcSEcCtD
Pentoxifylline—Vision blurred—Epirubicin—liver cancer	0.00154	0.00292	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Epirubicin—liver cancer	0.00152	0.00287	CcSEcCtD
Pentoxifylline—Erythema—Doxorubicin—liver cancer	0.00151	0.00286	CcSEcCtD
Pentoxifylline—Anaemia—Epirubicin—liver cancer	0.00151	0.00286	CcSEcCtD
Pentoxifylline—Agitation—Epirubicin—liver cancer	0.0015	0.00284	CcSEcCtD
Pentoxifylline—Flatulence—Doxorubicin—liver cancer	0.00149	0.00282	CcSEcCtD
Pentoxifylline—Tension—Doxorubicin—liver cancer	0.00148	0.00281	CcSEcCtD
Pentoxifylline—Dysgeusia—Doxorubicin—liver cancer	0.00148	0.0028	CcSEcCtD
Pentoxifylline—Malaise—Epirubicin—liver cancer	0.00147	0.00279	CcSEcCtD
Pentoxifylline—Nervousness—Doxorubicin—liver cancer	0.00147	0.00278	CcSEcCtD
Pentoxifylline—Leukopenia—Epirubicin—liver cancer	0.00146	0.00277	CcSEcCtD
Pentoxifylline—Back pain—Doxorubicin—liver cancer	0.00146	0.00277	CcSEcCtD
Pentoxifylline—Muscle spasms—Doxorubicin—liver cancer	0.00145	0.00275	CcSEcCtD
Pentoxifylline—Palpitations—Epirubicin—liver cancer	0.00144	0.00273	CcSEcCtD
Pentoxifylline—Vision blurred—Doxorubicin—liver cancer	0.00143	0.0027	CcSEcCtD
Pentoxifylline—Convulsion—Epirubicin—liver cancer	0.00142	0.00268	CcSEcCtD
Pentoxifylline—Hypertension—Epirubicin—liver cancer	0.00141	0.00267	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Doxorubicin—liver cancer	0.0014	0.00266	CcSEcCtD
Pentoxifylline—Anaemia—Doxorubicin—liver cancer	0.0014	0.00265	CcSEcCtD
Pentoxifylline—Chest pain—Epirubicin—liver cancer	0.00139	0.00263	CcSEcCtD
Pentoxifylline—Myalgia—Epirubicin—liver cancer	0.00139	0.00263	CcSEcCtD
Pentoxifylline—Agitation—Doxorubicin—liver cancer	0.00139	0.00263	CcSEcCtD
Pentoxifylline—Anxiety—Epirubicin—liver cancer	0.00139	0.00262	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00138	0.00262	CcSEcCtD
Pentoxifylline—Discomfort—Epirubicin—liver cancer	0.00137	0.0026	CcSEcCtD
Pentoxifylline—Malaise—Doxorubicin—liver cancer	0.00136	0.00258	CcSEcCtD
Pentoxifylline—Dry mouth—Epirubicin—liver cancer	0.00136	0.00258	CcSEcCtD
Pentoxifylline—Leukopenia—Doxorubicin—liver cancer	0.00135	0.00256	CcSEcCtD
Pentoxifylline—Confusional state—Epirubicin—liver cancer	0.00134	0.00255	CcSEcCtD
Pentoxifylline—Palpitations—Doxorubicin—liver cancer	0.00134	0.00253	CcSEcCtD
Pentoxifylline—Oedema—Epirubicin—liver cancer	0.00133	0.00253	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Epirubicin—liver cancer	0.00133	0.00253	CcSEcCtD
Pentoxifylline—Infection—Epirubicin—liver cancer	0.00133	0.00251	CcSEcCtD
Pentoxifylline—Shock—Epirubicin—liver cancer	0.00131	0.00248	CcSEcCtD
Pentoxifylline—Convulsion—Doxorubicin—liver cancer	0.00131	0.00248	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Epirubicin—liver cancer	0.00131	0.00247	CcSEcCtD
Pentoxifylline—Hypertension—Doxorubicin—liver cancer	0.00131	0.00247	CcSEcCtD
Pentoxifylline—Tachycardia—Epirubicin—liver cancer	0.0013	0.00246	CcSEcCtD
Pentoxifylline—Skin disorder—Epirubicin—liver cancer	0.0013	0.00245	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Epirubicin—liver cancer	0.00129	0.00244	CcSEcCtD
Pentoxifylline—Myalgia—Doxorubicin—liver cancer	0.00129	0.00244	CcSEcCtD
Pentoxifylline—Chest pain—Doxorubicin—liver cancer	0.00129	0.00244	CcSEcCtD
Pentoxifylline—Anxiety—Doxorubicin—liver cancer	0.00128	0.00243	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00128	0.00242	CcSEcCtD
Pentoxifylline—Discomfort—Doxorubicin—liver cancer	0.00127	0.00241	CcSEcCtD
Pentoxifylline—Anorexia—Epirubicin—liver cancer	0.00127	0.00241	CcSEcCtD
Pentoxifylline—Dry mouth—Doxorubicin—liver cancer	0.00126	0.00238	CcSEcCtD
Pentoxifylline—Hypotension—Epirubicin—liver cancer	0.00125	0.00236	CcSEcCtD
Pentoxifylline—Confusional state—Doxorubicin—liver cancer	0.00124	0.00236	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Doxorubicin—liver cancer	0.00123	0.00234	CcSEcCtD
Pentoxifylline—Oedema—Doxorubicin—liver cancer	0.00123	0.00234	CcSEcCtD
Pentoxifylline—Infection—Doxorubicin—liver cancer	0.00123	0.00232	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00122	0.0023	CcSEcCtD
Pentoxifylline—Shock—Doxorubicin—liver cancer	0.00121	0.0023	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Doxorubicin—liver cancer	0.00121	0.00229	CcSEcCtD
Pentoxifylline—Insomnia—Epirubicin—liver cancer	0.00121	0.00228	CcSEcCtD
Pentoxifylline—Tachycardia—Doxorubicin—liver cancer	0.0012	0.00228	CcSEcCtD
Pentoxifylline—Skin disorder—Doxorubicin—liver cancer	0.0012	0.00227	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Doxorubicin—liver cancer	0.00119	0.00226	CcSEcCtD
Pentoxifylline—Dyspnoea—Epirubicin—liver cancer	0.00119	0.00225	CcSEcCtD
Pentoxifylline—Somnolence—Epirubicin—liver cancer	0.00119	0.00224	CcSEcCtD
Pentoxifylline—Anorexia—Doxorubicin—liver cancer	0.00118	0.00223	CcSEcCtD
Pentoxifylline—Dyspepsia—Epirubicin—liver cancer	0.00117	0.00222	CcSEcCtD
Pentoxifylline—Decreased appetite—Epirubicin—liver cancer	0.00116	0.00219	CcSEcCtD
Pentoxifylline—Hypotension—Doxorubicin—liver cancer	0.00115	0.00218	CcSEcCtD
Pentoxifylline—Constipation—Epirubicin—liver cancer	0.00114	0.00216	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00112	0.00213	CcSEcCtD
Pentoxifylline—Insomnia—Doxorubicin—liver cancer	0.00112	0.00211	CcSEcCtD
Pentoxifylline—Dyspnoea—Doxorubicin—liver cancer	0.0011	0.00208	CcSEcCtD
Pentoxifylline—Feeling abnormal—Epirubicin—liver cancer	0.0011	0.00208	CcSEcCtD
Pentoxifylline—Somnolence—Doxorubicin—liver cancer	0.0011	0.00208	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Epirubicin—liver cancer	0.00109	0.00206	CcSEcCtD
Pentoxifylline—Dyspepsia—Doxorubicin—liver cancer	0.00109	0.00206	CcSEcCtD
Pentoxifylline—Decreased appetite—Doxorubicin—liver cancer	0.00107	0.00203	CcSEcCtD
Pentoxifylline—Urticaria—Epirubicin—liver cancer	0.00106	0.00201	CcSEcCtD
Pentoxifylline—Constipation—Doxorubicin—liver cancer	0.00106	0.002	CcSEcCtD
Pentoxifylline—Abdominal pain—Epirubicin—liver cancer	0.00105	0.002	CcSEcCtD
Pentoxifylline—Body temperature increased—Epirubicin—liver cancer	0.00105	0.002	CcSEcCtD
Pentoxifylline—Feeling abnormal—Doxorubicin—liver cancer	0.00102	0.00193	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Doxorubicin—liver cancer	0.00101	0.00191	CcSEcCtD
Pentoxifylline—Hypersensitivity—Epirubicin—liver cancer	0.000983	0.00186	CcSEcCtD
Pentoxifylline—Urticaria—Doxorubicin—liver cancer	0.00098	0.00186	CcSEcCtD
Pentoxifylline—Abdominal pain—Doxorubicin—liver cancer	0.000976	0.00185	CcSEcCtD
Pentoxifylline—Body temperature increased—Doxorubicin—liver cancer	0.000976	0.00185	CcSEcCtD
Pentoxifylline—Asthenia—Epirubicin—liver cancer	0.000957	0.00181	CcSEcCtD
Pentoxifylline—Pruritus—Epirubicin—liver cancer	0.000944	0.00179	CcSEcCtD
Pentoxifylline—Diarrhoea—Epirubicin—liver cancer	0.000913	0.00173	CcSEcCtD
Pentoxifylline—Hypersensitivity—Doxorubicin—liver cancer	0.000909	0.00172	CcSEcCtD
Pentoxifylline—Asthenia—Doxorubicin—liver cancer	0.000885	0.00168	CcSEcCtD
Pentoxifylline—Dizziness—Epirubicin—liver cancer	0.000882	0.00167	CcSEcCtD
Pentoxifylline—Pruritus—Doxorubicin—liver cancer	0.000873	0.00165	CcSEcCtD
Pentoxifylline—Vomiting—Epirubicin—liver cancer	0.000848	0.00161	CcSEcCtD
Pentoxifylline—Diarrhoea—Doxorubicin—liver cancer	0.000844	0.0016	CcSEcCtD
Pentoxifylline—Rash—Epirubicin—liver cancer	0.000841	0.00159	CcSEcCtD
Pentoxifylline—Dermatitis—Epirubicin—liver cancer	0.00084	0.00159	CcSEcCtD
Pentoxifylline—Headache—Epirubicin—liver cancer	0.000836	0.00158	CcSEcCtD
Pentoxifylline—Dizziness—Doxorubicin—liver cancer	0.000816	0.00154	CcSEcCtD
Pentoxifylline—Nausea—Epirubicin—liver cancer	0.000792	0.0015	CcSEcCtD
Pentoxifylline—Vomiting—Doxorubicin—liver cancer	0.000785	0.00149	CcSEcCtD
Pentoxifylline—Rash—Doxorubicin—liver cancer	0.000778	0.00147	CcSEcCtD
Pentoxifylline—Dermatitis—Doxorubicin—liver cancer	0.000777	0.00147	CcSEcCtD
Pentoxifylline—Headache—Doxorubicin—liver cancer	0.000773	0.00146	CcSEcCtD
Pentoxifylline—Nausea—Doxorubicin—liver cancer	0.000733	0.00139	CcSEcCtD
Pentoxifylline—CYP1A2—Metabolism—TAT—liver cancer	0.000168	0.000407	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2—liver cancer	0.000168	0.000405	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK14—liver cancer	0.000167	0.000404	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TERT—liver cancer	0.000167	0.000404	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CD—liver cancer	0.000167	0.000403	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000165	0.0004	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ESR1—liver cancer	0.000164	0.000397	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—F2—liver cancer	0.000162	0.000392	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2—liver cancer	0.000157	0.00038	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TERT—liver cancer	0.000156	0.000378	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2—liver cancer	0.000155	0.000375	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CG—liver cancer	0.000155	0.000375	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APC—liver cancer	0.000155	0.000375	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TERT—liver cancer	0.000155	0.000374	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PRKCE—liver cancer	0.000153	0.00037	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KDR—liver cancer	0.000153	0.00037	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK14—liver cancer	0.000152	0.000367	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CD—liver cancer	0.000151	0.000366	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ESR1—liver cancer	0.000149	0.00036	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—F2—liver cancer	0.000147	0.000356	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—BRAF—liver cancer	0.000146	0.000352	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CB—liver cancer	0.000145	0.000352	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF2—liver cancer	0.000145	0.000351	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KDR—liver cancer	0.000143	0.000346	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK14—liver cancer	0.000142	0.000344	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KDR—liver cancer	0.000141	0.000342	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APC—liver cancer	0.000141	0.00034	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CG—liver cancer	0.000141	0.00034	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK14—liver cancer	0.00014	0.00034	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—AKT1—liver cancer	0.00014	0.000338	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ESR1—liver cancer	0.000139	0.000337	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ESR1—liver cancer	0.000138	0.000333	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—F2—liver cancer	0.000138	0.000333	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CD—liver cancer	0.000136	0.00033	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—F2—liver cancer	0.000136	0.000329	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CSF2—liver cancer	0.000136	0.000328	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—RAF1—liver cancer	0.000135	0.000327	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PIK3CA—liver cancer	0.000135	0.000326	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SERPINE1—liver cancer	0.000135	0.000326	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—H2AFX—liver cancer	0.000134	0.000323	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2—liver cancer	0.000133	0.000323	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—KRAS—liver cancer	0.000133	0.000323	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—BRAF—liver cancer	0.000132	0.00032	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CB—liver cancer	0.000132	0.000319	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CG—liver cancer	0.000132	0.000319	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APC—liver cancer	0.000132	0.000319	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CG—liver cancer	0.00013	0.000315	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APC—liver cancer	0.00013	0.000315	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—BRAF—liver cancer	0.000124	0.0003	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000124	0.000299	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CD—liver cancer	0.000124	0.000299	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PIK3CA—liver cancer	0.000123	0.000296	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PIK3CA—liver cancer	0.000123	0.000296	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—BRAF—liver cancer	0.000122	0.000296	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SERPINE1—liver cancer	0.000122	0.000296	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RAF1—liver cancer	0.000122	0.000294	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2—liver cancer	0.000121	0.000293	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—KRAS—liver cancer	0.000121	0.000293	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TERT—liver cancer	0.000121	0.000292	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MTOR—liver cancer	0.000119	0.000287	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CB—liver cancer	0.000119	0.000287	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CD—liver cancer	0.000116	0.00028	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CA—liver cancer	0.000115	0.000278	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SERPINE1—liver cancer	0.000115	0.000277	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CD—liver cancer	0.000114	0.000277	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CPT1B—liver cancer	0.000114	0.000276	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GLUL—liver cancer	0.000114	0.000276	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—KRAS—liver cancer	0.000113	0.000274	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CA—liver cancer	0.000113	0.000274	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRAS—liver cancer	0.000113	0.000274	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SERPINE1—liver cancer	0.000113	0.000274	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—KRAS—liver cancer	0.000112	0.000271	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1B—liver cancer	0.000111	0.00027	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CA—liver cancer	0.000111	0.000269	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RAF1—liver cancer	0.00011	0.000267	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KDR—liver cancer	0.00011	0.000267	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKT1—liver cancer	0.00011	0.000267	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NR1H4—liver cancer	0.00011	0.000266	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK14—liver cancer	0.00011	0.000265	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CASP3—liver cancer	0.000109	0.000264	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2—liver cancer	0.000109	0.000264	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—liver cancer	0.000109	0.000262	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTA3—liver cancer	0.000108	0.000262	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MTOR—liver cancer	0.000108	0.000261	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CB—liver cancer	0.000108	0.000261	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ESR1—liver cancer	0.000108	0.00026	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCND1—liver cancer	0.000106	0.000257	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—F2—liver cancer	0.000106	0.000257	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—JUN—liver cancer	0.000106	0.000257	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CTNNB1—liver cancer	0.000105	0.000255	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CA—liver cancer	0.000104	0.000252	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RAF1—liver cancer	0.000103	0.00025	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MMP9—liver cancer	0.000103	0.00025	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CA—liver cancer	0.000103	0.000249	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRAS—liver cancer	0.000103	0.000249	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CDKN1A—liver cancer	0.000103	0.000249	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RAF1—liver cancer	0.000102	0.000247	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CG—liver cancer	0.000102	0.000246	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APC—liver cancer	0.000102	0.000246	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1B—liver cancer	0.000101	0.000245	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CB—liver cancer	0.000101	0.000244	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MTOR—liver cancer	0.000101	0.000244	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK8—liver cancer	0.0001	0.000243	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKT1—liver cancer	0.0001	0.000242	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKT1—liver cancer	0.0001	0.000242	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MTOR—liver cancer	9.98e-05	0.000241	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CB—liver cancer	9.98e-05	0.000241	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CASP3—liver cancer	9.92e-05	0.00024	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTA4—liver cancer	9.91e-05	0.00024	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2—liver cancer	9.9e-05	0.00024	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—liver cancer	9.86e-05	0.000238	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	9.68e-05	0.000234	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCND1—liver cancer	9.66e-05	0.000234	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTA2—liver cancer	9.65e-05	0.000233	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRAS—liver cancer	9.64e-05	0.000233	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—JUN—liver cancer	9.64e-05	0.000233	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—BRAF—liver cancer	9.56e-05	0.000231	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CTNNB1—liver cancer	9.56e-05	0.000231	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRAS—liver cancer	9.53e-05	0.00023	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1B—liver cancer	9.48e-05	0.000229	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKT1—liver cancer	9.38e-05	0.000227	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MMP9—liver cancer	9.37e-05	0.000227	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1B—liver cancer	9.36e-05	0.000226	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDKN1A—liver cancer	9.34e-05	0.000226	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTA1—liver cancer	9.31e-05	0.000225	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CASP3—liver cancer	9.29e-05	0.000225	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2—liver cancer	9.27e-05	0.000224	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—liver cancer	9.27e-05	0.000224	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKT1—liver cancer	9.26e-05	0.000224	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—liver cancer	9.23e-05	0.000223	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NAT2—liver cancer	9.21e-05	0.000223	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STAT3—liver cancer	9.18e-05	0.000222	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CASP3—liver cancer	9.18e-05	0.000222	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2—liver cancer	9.16e-05	0.000222	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—liver cancer	9.12e-05	0.000221	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK8—liver cancer	9.12e-05	0.00022	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKT1—liver cancer	9.09e-05	0.00022	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCND1—liver cancer	9.04e-05	0.000219	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—JUN—liver cancer	9.02e-05	0.000218	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CTNNB1—liver cancer	8.95e-05	0.000217	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CD—liver cancer	8.95e-05	0.000216	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCND1—liver cancer	8.93e-05	0.000216	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—JUN—liver cancer	8.92e-05	0.000216	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CA—liver cancer	8.86e-05	0.000214	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	8.86e-05	0.000214	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SERPINE1—liver cancer	8.85e-05	0.000214	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CTNNB1—liver cancer	8.85e-05	0.000214	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALDOB—liver cancer	8.83e-05	0.000214	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MMP9—liver cancer	8.78e-05	0.000212	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—KRAS—liver cancer	8.76e-05	0.000212	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDKN1A—liver cancer	8.75e-05	0.000212	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MMP9—liver cancer	8.67e-05	0.00021	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDKN1A—liver cancer	8.64e-05	0.000209	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK8—liver cancer	8.54e-05	0.000206	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—liver cancer	8.53e-05	0.000206	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKT1—liver cancer	8.51e-05	0.000206	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TGFB1—liver cancer	8.51e-05	0.000206	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK8—liver cancer	8.44e-05	0.000204	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CRABP1—liver cancer	8.42e-05	0.000204	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—liver cancer	8.42e-05	0.000204	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKT1—liver cancer	8.41e-05	0.000203	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STAT3—liver cancer	8.33e-05	0.000202	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CA—liver cancer	8.05e-05	0.000195	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RAF1—liver cancer	7.99e-05	0.000193	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—liver cancer	7.88e-05	0.000191	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KRAS—liver cancer	7.88e-05	0.000191	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STAT3—liver cancer	7.8e-05	0.000189	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CB—liver cancer	7.8e-05	0.000189	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MTOR—liver cancer	7.8e-05	0.000189	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—liver cancer	7.79e-05	0.000188	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—liver cancer	7.74e-05	0.000187	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TGFB1—liver cancer	7.73e-05	0.000187	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STAT3—liver cancer	7.71e-05	0.000187	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.58e-05	0.000183	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRAS—liver cancer	7.44e-05	0.00018	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HPGDS—liver cancer	7.36e-05	0.000178	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	7.32e-05	0.000177	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1B—liver cancer	7.32e-05	0.000177	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—liver cancer	7.25e-05	0.000175	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CA—liver cancer	7.24e-05	0.000175	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKT1—liver cancer	7.24e-05	0.000175	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TGFB1—liver cancer	7.23e-05	0.000175	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CASP3—liver cancer	7.17e-05	0.000173	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—liver cancer	7.17e-05	0.000173	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2—liver cancer	7.16e-05	0.000173	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KRAS—liver cancer	7.16e-05	0.000173	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TGFB1—liver cancer	7.15e-05	0.000173	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—liver cancer	7.13e-05	0.000172	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—liver cancer	7e-05	0.000169	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCND1—liver cancer	6.98e-05	0.000169	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JUN—liver cancer	6.97e-05	0.000168	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CTNNB1—liver cancer	6.91e-05	0.000167	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MMP9—liver cancer	6.78e-05	0.000164	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDKN1A—liver cancer	6.75e-05	0.000163	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KRAS—liver cancer	6.7e-05	0.000162	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRAS—liver cancer	6.7e-05	0.000162	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.67e-05	0.000161	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KRAS—liver cancer	6.62e-05	0.00016	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK8—liver cancer	6.59e-05	0.000159	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.58e-05	0.000159	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CA—liver cancer	6.57e-05	0.000159	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT1—liver cancer	6.57e-05	0.000159	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PSMA4—liver cancer	6.56e-05	0.000159	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PSMD10—liver cancer	6.56e-05	0.000159	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—liver cancer	6.41e-05	0.000155	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GOT2—liver cancer	6.38e-05	0.000154	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—liver cancer	6.36e-05	0.000154	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CA—liver cancer	6.16e-05	0.000149	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—liver cancer	6.09e-05	0.000147	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CA—liver cancer	6.08e-05	0.000147	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRAS—liver cancer	6.08e-05	0.000147	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STAT3—liver cancer	6.03e-05	0.000146	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2E1—liver cancer	6e-05	0.000145	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—liver cancer	5.96e-05	0.000144	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT1—liver cancer	5.91e-05	0.000143	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—liver cancer	5.88e-05	0.000142	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—liver cancer	5.82e-05	0.000141	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.81e-05	0.000141	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRAS—liver cancer	5.7e-05	0.000138	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRAS—liver cancer	5.63e-05	0.000136	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYCS—liver cancer	5.62e-05	0.000136	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—liver cancer	5.6e-05	0.000135	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TGFB1—liver cancer	5.59e-05	0.000135	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GOT1—liver cancer	5.51e-05	0.000133	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GGT1—liver cancer	5.51e-05	0.000133	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—liver cancer	5.45e-05	0.000132	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—liver cancer	5.39e-05	0.00013	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT1—liver cancer	5.37e-05	0.00013	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KRAS—liver cancer	5.17e-05	0.000125	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT1—liver cancer	5.03e-05	0.000122	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT1—liver cancer	4.97e-05	0.00012	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTP1—liver cancer	4.95e-05	0.00012	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HMOX1—liver cancer	4.88e-05	0.000118	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CA—liver cancer	4.75e-05	0.000115	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—liver cancer	4.6e-05	0.000111	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTM1—liver cancer	4.55e-05	0.00011	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRAS—liver cancer	4.4e-05	0.000106	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP1A1—liver cancer	4.31e-05	0.000104	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—liver cancer	4.21e-05	0.000102	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MTHFR—liver cancer	4.02e-05	9.72e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARA—liver cancer	3.94e-05	9.54e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT1—liver cancer	3.88e-05	9.39e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.54e-05	8.57e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CG—liver cancer	3.38e-05	8.17e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARG—liver cancer	3.26e-05	7.88e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CD—liver cancer	2.97e-05	7.18e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALB—liver cancer	2.93e-05	7.09e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CB—liver cancer	2.59e-05	6.26e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CA—liver cancer	1.58e-05	3.82e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKT1—liver cancer	1.29e-05	3.12e-05	CbGpPWpGaD
